Actualités
Communiqué de Presse
07/11/2018
Service partnership agreement between Oncodesign and Galderma
Press Release: Multi-year service contract: design and discover new drug candidates in dermatology - Galderma.
Communiqué de Presse
15/10/2018
Centre Georges François Leclerc Presents the Detailed Results of the First Two Stages of its Clinical Study in Lung Cancer at the EANM Congress
Presentation of detailed results from the first two stages of the clinical trial in lung cancer | 31st EANM1 | 2018.
Communiqué de Presse
18/09/2018
Precision medicine: Cap Digital and Medicen Paris-Region team-up with Oncodesign, Servier and Intersystems on Hu-PreciMED
Hu-PreciMED project will gear French precision medicine industry towards discovering new diagnostic approaches & novel therapeutic treatments.
Communiqué de Presse
06/09/2018
Oncodesign furthers its cooperation with Eisai, started 12 years ago
This services agreement aims to evaluate the anti-tumor efficacy of Eisai new compounds...
Communiqué de Presse
03/07/2018
Oncodesign announces the results of the second stage of its clinical study in lung cancer
The results confirm the radiotracer’s potential as a companion biomarker for patientssuffering from non-small-cell lung cancer.